ATE535807T1 - Gensignaturen - Google Patents
GensignaturenInfo
- Publication number
- ATE535807T1 ATE535807T1 AT09728011T AT09728011T ATE535807T1 AT E535807 T1 ATE535807 T1 AT E535807T1 AT 09728011 T AT09728011 T AT 09728011T AT 09728011 T AT09728011 T AT 09728011T AT E535807 T1 ATE535807 T1 AT E535807T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- molecules
- tissue
- correlating
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
- G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Paper (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7297108P | 2008-04-03 | 2008-04-03 | |
| US12820508P | 2008-05-19 | 2008-05-19 | |
| GBGB0809069.8A GB0809069D0 (en) | 2008-05-19 | 2008-05-19 | Gene signatures |
| US20070508P | 2008-12-02 | 2008-12-02 | |
| PCT/BE2009/000022 WO2009121152A2 (en) | 2008-04-03 | 2009-04-02 | Gene signatures |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE535807T1 true ATE535807T1 (de) | 2011-12-15 |
Family
ID=39596133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT09728011T ATE535807T1 (de) | 2008-04-03 | 2009-04-02 | Gensignaturen |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110053167A1 (de) |
| EP (1) | EP2260301B9 (de) |
| AT (1) | ATE535807T1 (de) |
| CA (1) | CA2712331A1 (de) |
| DK (1) | DK2260301T3 (de) |
| GB (1) | GB0809069D0 (de) |
| WO (1) | WO2009121152A2 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201704689XA (en) | 2008-01-18 | 2017-07-28 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| SG10201505723UA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
| CA2806304A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
| CA2806301A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting cardiovascular diseases or conditions |
| MX2013000917A (es) | 2010-07-23 | 2013-07-05 | Harvard College | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. |
| WO2012072685A1 (en) | 2010-12-02 | 2012-06-07 | Katholieke Universiteit Leuven, K.U.Leuven R&D | Irak-related interventions and diagnosis |
| EP2653555A1 (de) * | 2012-04-19 | 2013-10-23 | Fundacion Centro Nacional De Investigaciones Cardiovasculares Carlos III (CINC) | P38-MAPK-gamma und -delta zur Verwendung als Biomarker von Nichtalkoholischer Fettleberhepatitis |
| CN104603289A (zh) | 2012-06-15 | 2015-05-06 | 哈里·斯泰利 | 检测疾病或病状的方法 |
| EA201590024A1 (ru) | 2012-06-15 | 2015-05-29 | Гарри Стилли | Способы определения заболеваний или состояний с применением циркулирующих болезненных клеток |
| US9081854B2 (en) * | 2012-07-06 | 2015-07-14 | Hewlett-Packard Development Company, L.P. | Multilabel classification by a hierarchy |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| WO2015081391A1 (en) * | 2013-12-05 | 2015-06-11 | Katholieke Universiteit Leuven Ku Leuven Research & Development | Resistance to oxidative stress |
| EP3189141B1 (de) * | 2014-09-02 | 2020-06-24 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Gegen die a20 3'-utr region gerichtete antisense-oligonukleotide |
| EP4428251A3 (de) | 2014-09-11 | 2024-12-18 | Immunis.AI, Inc. | Verfahren zum nachweis von prostatakrebs |
| WO2016094970A1 (en) | 2014-12-19 | 2016-06-23 | Vrije Universiteit Brussel | In vitro maturation of a mammalian cumulus oocyte complex |
| PL237595B1 (pl) * | 2017-07-28 | 2021-05-04 | Univ Medyczny W Bialymstoku | Sposób oznaczania wrażliwości tkanek na insulinę oraz sposób identyfikacji insulinooporności i/lub określania predyspozycji do zaburzenia z nią związanego |
| TWI634902B (zh) * | 2017-10-28 | 2018-09-11 | 醫療財團法人徐元智先生醫藥基金會亞東紀念醫院 | Use of glucosamine peptide compounds for the treatment of abnormal liver metabolism |
| WO2020210487A1 (en) * | 2019-04-12 | 2020-10-15 | Cipher Genetics Inc. | Systems and methods for nutrigenomics and nutrigenetic analysis |
| CN113208114B (zh) * | 2020-07-14 | 2022-12-20 | 内蒙古蒙牛乳业(集团)股份有限公司 | 嗜热链球菌mn002在脂代谢调节中的用途及膳食补充剂 |
| CN113355410A (zh) * | 2021-07-09 | 2021-09-07 | 川北医学院附属医院 | 一种原发性痛风诊断标志物及应用 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| DE69334275D1 (de) | 1992-08-21 | 2009-05-20 | Univ Bruxelles | Immunoglobuline ohne Leichtkette |
| WO1994025591A1 (en) | 1993-04-29 | 1994-11-10 | Unilever N.V. | PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| EP0698097B1 (de) | 1993-04-29 | 2001-08-16 | Unilever N.V. | Herstellung von antikörpern oder funktionstüchtig gemachten teilen davon, abgeleitet von schweren ketten von immunglobulinen von camelidae |
| EP0739981A1 (de) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable Fragmente von Immunglobulinen-Verwendung zur therapeutischen oder veterinären Zwecken |
| EP0880598A4 (de) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Verfahren zur analyse von nukleinsäure |
| ATE374248T1 (de) | 1996-06-27 | 2007-10-15 | Vlaams Interuniv Inst Biotech | Antikörpermoleküle, die spezifisch mit dem aktiven zentrum oder dem aktiven spalt eines zielmoleküls interagieren |
| US7348181B2 (en) | 1997-10-06 | 2008-03-25 | Trustees Of Tufts College | Self-encoding sensor with microspheres |
| JP2001521753A (ja) | 1997-10-31 | 2001-11-13 | アフィメトリックス インコーポレイテッド | 成人臓器及び胎児臓器中の発現プロフィール |
| US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
| US6262228B1 (en) * | 1998-08-17 | 2001-07-17 | Tularik Inc. | IRAK3 polypeptides and methods |
| ATE276359T1 (de) | 1999-01-19 | 2004-10-15 | Unilever Nv | Verfahren zur herstellung von antikörperfragmenten |
| AU779752B2 (en) | 1999-05-19 | 2005-02-10 | Eppendorf Array Technologies S.A. | Method for the identification and/or the quantification of a target compound |
| US7371516B1 (en) | 1999-07-16 | 2008-05-13 | Rosetta Inpharmatics Llc | Methods for determining the specificity and sensitivity of oligonucleo tides for hybridization |
| US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
| ATE342922T1 (de) | 1999-11-29 | 2006-11-15 | Unilever Nv | Immobilisierung von proteinen mit hilfe eines polypeptidsegments |
| US6618679B2 (en) | 2000-01-28 | 2003-09-09 | Althea Technologies, Inc. | Methods for analysis of gene expression |
| US20030190598A1 (en) | 2000-05-26 | 2003-10-09 | Jasmid Tanha | Single-domain antigen-binding antibody fragments derived from llama antibodies |
| JP2002262876A (ja) | 2001-03-07 | 2002-09-17 | Ngk Insulators Ltd | 高感度な核酸のハイブリダイゼーション方法、及びその方法を用いた遺伝子解析方法 |
| US7047141B2 (en) | 2001-03-22 | 2006-05-16 | Ge Healthcare Bio-Sciences Ab | Ratio-based oligonucleotide probe selection |
| GB0110029D0 (en) | 2001-04-24 | 2001-06-13 | Grosveld Frank | Transgenic animal |
| US7138506B2 (en) | 2001-05-09 | 2006-11-21 | Genetic Id, Na, Inc. | Universal microarray system |
| US20050271663A1 (en) | 2001-06-28 | 2005-12-08 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
| WO2003016574A1 (en) | 2001-08-16 | 2003-02-27 | Zhifeng Shao | Analysis of gene expression profiles using sequential hybridization |
| JP4213586B2 (ja) | 2001-09-13 | 2009-01-21 | 株式会社抗体研究所 | ラクダ抗体ライブラリーの作製方法 |
| US7439346B2 (en) | 2001-10-12 | 2008-10-21 | Perkinelmer Las Inc. | Nucleic acids arrays and methods of use therefor |
| CA2463725A1 (en) | 2001-10-12 | 2003-11-06 | Spectral Genomics, Inc. | Compilations of nucleic acids and arrays and methods of using them |
| AU2003224603A1 (en) * | 2002-01-22 | 2003-10-08 | The Regents Of The University Of California | Potentiation of cancer therapies by znf217 inhibition |
| US7221785B2 (en) | 2002-05-21 | 2007-05-22 | Agilent Technologies, Inc. | Method and system for measuring a molecular array background signal from a continuous background region of specified size |
| US7031845B2 (en) | 2002-07-19 | 2006-04-18 | University Of Chicago | Method for determining biological expression levels by linear programming |
| NZ540194A (en) | 2002-11-08 | 2008-07-31 | Ablynx Nv | Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| US20060034845A1 (en) | 2002-11-08 | 2006-02-16 | Karen Silence | Single domain antibodies directed against tumor necrosis factor alpha and uses therefor |
| CA2463719A1 (en) | 2003-04-05 | 2004-10-05 | F. Hoffmann-La Roche Ag | Nucleotide analogs with six membered rings |
| US7347921B2 (en) | 2003-07-17 | 2008-03-25 | Agilent Technologies, Inc. | Apparatus and method for threading a biopolymer through a nanopore |
| US7353116B2 (en) | 2003-07-31 | 2008-04-01 | Agilent Technologies, Inc. | Chemical array with test dependent signal reading or processing |
| GB0323238D0 (en) | 2003-10-03 | 2003-11-05 | Domantis Ltd | Synthetic LG binding domains of protein L |
| WO2005052132A2 (en) * | 2003-11-24 | 2005-06-09 | Exelixis, Inc | Mbms as modifiers of branching morphogenesis and methods of use |
| US7302348B2 (en) | 2004-06-02 | 2007-11-27 | Agilent Technologies, Inc. | Method and system for quantifying and removing spatial-intensity trends in microarray data |
| US7323308B2 (en) | 2004-09-03 | 2008-01-29 | Affymetrix, Inc. | Methods of genetic analysis of E. coli |
| US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
| SI1836500T1 (sl) | 2005-01-14 | 2010-11-30 | Ablynx Nv | Postopki in testi za razlikovanje med različnimioblikami bolezni in motenj ki so označene s trombocitopenijo in ali s spontano interakcijo med von Willebrandovim faktorjem vWF in krvnimi ploščicami |
| WO2006083798A2 (en) * | 2005-01-31 | 2006-08-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating obesity-related disorders by inhibiting myd88 and methods for identifying myd88 inhibitors |
| AU2006249144B2 (en) | 2005-05-18 | 2011-11-17 | Ablynx Nv | Improved NanobodiesTM against Tumor Necrosis Factor-alpha |
| JP2009517069A (ja) | 2005-12-01 | 2009-04-30 | ドマンティス リミテッド | インターロイキン1受容体1型に結合する競合ドメイン抗体フォーマット |
| CA2632866A1 (en) | 2005-12-01 | 2007-06-07 | Domantis Limited | Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
-
2008
- 2008-05-19 GB GBGB0809069.8A patent/GB0809069D0/en not_active Ceased
-
2009
- 2009-04-02 DK DK09728011.9T patent/DK2260301T3/da active
- 2009-04-02 CA CA2712331A patent/CA2712331A1/en not_active Abandoned
- 2009-04-02 AT AT09728011T patent/ATE535807T1/de active
- 2009-04-02 EP EP09728011A patent/EP2260301B9/de not_active Not-in-force
- 2009-04-02 US US12/922,739 patent/US20110053167A1/en not_active Abandoned
- 2009-04-02 WO PCT/BE2009/000022 patent/WO2009121152A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB0809069D0 (en) | 2008-06-25 |
| CA2712331A1 (en) | 2009-10-08 |
| EP2260301B9 (de) | 2012-07-11 |
| EP2260301B1 (de) | 2011-11-30 |
| EP2260301A2 (de) | 2010-12-15 |
| DK2260301T3 (da) | 2012-03-12 |
| WO2009121152A2 (en) | 2009-10-08 |
| WO2009121152A3 (en) | 2009-12-17 |
| US20110053167A1 (en) | 2011-03-03 |
| WO2009121152A8 (en) | 2011-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0809069D0 (en) | Gene signatures | |
| WO2008073919A3 (en) | Mir-20 regulated genes and pathways as targets for therapeutic intervention | |
| Huang et al. | Circular RNA ciRS-7 triggers the migration and invasion of esophageal squamous cell carcinoma via miR-7/KLF4 and NF-κB signals | |
| WO2008154333A3 (en) | Mir-34 regulated genes and pathways as targets for therapeutic intervention | |
| WO2008036741A3 (en) | Mir-200 regulated genes and pathways as targets for therapeutic intervention | |
| WO2009086156A3 (en) | Mir-10 regulated genes and pathways as targets for therapeutic intervention | |
| WO2009070805A3 (en) | Mir-124 regulated genes and pathways as targets for therapeutic intervention | |
| WO2008073920A3 (en) | Mir-21 regulated genes and pathways as targets for therapeutic intervention | |
| ATE534738T1 (de) | Mir-126-regulierte gene und pfade als ziele für therapeutische interventionen | |
| WO2009154835A3 (en) | Compositions and methods related to mir-16 and therapy of prostate cancer | |
| WO2008085797A3 (en) | miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION | |
| WO2009044899A1 (ja) | 細胞の増殖を制御する核酸 | |
| MX2022001797A (es) | Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un farmaco oral o no oral antidiabetico. | |
| WO2009114681A3 (en) | Identification of mirna profiles that are diagnostic of hypertrophic cardiomyopathy | |
| WO2009140569A3 (en) | Genetic markers for weight management and methods of use thereof | |
| MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
| WO2008082730A3 (en) | Biomarkers of target modulation, efficacy, diagnosis and/or prognosis for raf inhibitors | |
| WO2010048378A3 (en) | Genetic markers for weight management and methods of use thereof | |
| WO2011063098A3 (en) | Genetic markers for weight management and methods of use thereof | |
| WO2010004591A3 (en) | Genetic variants for breast cancer risk assessment | |
| MX2009012315A (es) | Metodos de identificacion de genes involucrados en la formacion de memoria utilizando arn pequeño de interferencia (arnip). | |
| BRPI0906549A2 (pt) | Bandagens médicas com válvulas e kits contendo as mesmas. | |
| WO2011017516A3 (en) | Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) | |
| MX2013004747A (es) | Marcadores de gen de sangre periferica para el diagnostico temprano de la enfermedad de parkinson. | |
| BR112015004653A2 (pt) | método diagnóstico e terapêutico de câncer de moléculas alvo expressas em células-tronco cancerígenas |